
Taha Qazi, MD: Impact of Bariatric Surgery on Cirrhosis, Liver Disease Outcomes
Qazi discusses the impact of bariatric surgery on outcomes in patients with decompensated cirrhosis, highlighting its benefit in this patient population.
Given recent increases in the prevalence of obesity, both
The sixth issue of
Investigators identified adult patients with obesity hospitalized with decompensated cirrhosis, including ascites, variceal hemorrhage, hepatic encephalopathy, or portal hypertension, stratified based on whether or not they had a history of bariatric surgery. Study results showed the bariatric surgery cohort had better outcomes for rates of inpatient mortality; acute kidney injury; respiratory failure requiring mechanical ventilation; and upper GI bleed. Although bariatric surgery was protective against inpatient mortality in univariate analysis, significance was lost in multivariate analysis.
“In these patients who received a bariatric procedure of some sort to alleviate their metabolic associated liver disease, they actually did very well, and I think that's a good thing to consider as our armamentarium of bariatric procedures improves,” Qazi, a gastroenterologist with the Cleveland Clinic, said to HCPLive.
Investigators pointed to improved outcomes among patients with obesity and a history of bariatric surgery hospitalized with decompensated cirrhosis compared to nonsurgical patients, something they said likely relates to overall improved metabolic and comorbid health conferred by bariatric surgery. However, they also called attention to the need for future analyses to better understand this relationship.











































































